PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Pfizer RSS Channel

Display # 
Title Published Date
Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction 08 February 2016
Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals 02 February 2016
Pfizer expands R&D equity investment strategy to access early-stage scientific innovations 13 January 2016
Merck KGaA, Darmstadt, Germany, Pfizer and Syndax announce collaboration to evaluate combination of Avelumab and Entinostat in ovarian cancer 04 January 2016
Global partners announce donation of 500 millionth dose of azithromycin 17 November 2015
Pfizer expands its patient assistance program 10 November 2015
Pfizer completes acquisition of Nimenrix and Mencevax from GlaxoSmithKline 06 October 2015
New Centrum® VitaMints® offer a refreshingly new way to take a multivitamin 24 September 2015
Pfizer and Synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis 04 August 2015
Pfizer's Centers for Therapeutic Innovation and Jeffrey Modell Foundation announce collaboration 13 July 2015
Pfizer enters into agreement to acquire Nimenrix and Mencevax from GlaxoSmithKline 23 June 2015
Get Ready. Get Set. Get Old. 04 June 2015
Pfizer announces $3 million grants program to further clinical research in advanced breast cancer 28 May 2015
Pfizer acquires minority interest in AM-Pharma; secures option to acquire company 11 May 2015
Pfizer and Lilly preparing to resume Phase 3 chronic pain program for Tanezumab 23 March 2015
Pfizer to Acquire Hospira 06 February 2015
Acquisition provides Pfizer with a preclinical CMV vaccine candidate 09 January 2015
Pfizer expands rare disease research with establishment of gene therapy platform 08 December 2014
Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study 30 September 2014
Pfizer and Merck to collaborate on study evaluating novel anti-cancer combination regimen 26 August 2014

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]